CTNM vs STE · $429.6M cap vs P/E 25, rev $5.94B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported STE revenue for 2026-03-31 was $5.94B. Net income was $782.3M. Revenue was up 8.7% from 2025-03-31 to 2026-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
CTNM currently screens at market cap $429.6M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the CTNM and STE stock pages for the full models.
Not investment advice.